deutivacaftor 50 MG / tezacaftor 20 MG / vanzacaftor 4 MG Oral Tablet [Alyftrek]
RxNorm concept 2701450, branded drug (sbd). Prescribable name: alyftrek 50 MG / 20 MG / 4 MG Oral Tablet.
- RxCUI
- 2701450
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2701450 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Alyftrek 50 MG / 20 MG / 4 MG (equivalent to vanzacaftor calcium dihydrate 4.24 MG) Oral Tablet
Related concepts
- vanzacaftor 4 MG (SCDC, consists of)
- tezacaftor 20 MG (SCDC, consists of)
- deutivacaftor 50 MG (SCDC, consists of)
- deutivacaftor 50 MG / tezacaftor 20 MG / vanzacaftor 4 MG [Alyftrek] (SBDC, consists of)
- Oral Tablet (DF, has dose form)
- Alyftrek (BN, has ingredient)
- deutivacaftor 50 MG / tezacaftor 20 MG / vanzacaftor 4 MG Oral Tablet (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2701450 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2701450 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2701450. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.